Medical
education
Contact us
Personalized learning with Medtronic Academy
Medtronic Academy provides healthcare professionals with unlimited access to the latest e-learning content for spinal cord stimulation therapies from Medtronic. Upon completion of any Medtronic Academy course you will have immediate access to your certificate of completion.
Gain access to:
- Continuing education credits for healthcare professionals
- Personalized learning pathways and curriculum
- Interactive courses, webcasts, and product feature information
- Procedural animations and videos
Take a step forward in how you treat chronic diabetic peripheral neuropathy
Spinal cord stimulation for your patients with moderate to severe diabetic peripheral neuropathy (DPN) pain
Help your patients control the debilitating pain in their feet and legs.
For patients who experience chronic pain due to DPN and have not been satisfied by the levels of relief provided by oral pain medication, injections, or other treatments for pain, SCS can provide a new approach for patients looking for solutions.
Potential benefits of SCS therapy
- Patients with DPN are 17 times more likely to experience significant pain relief if treated with SCS compared to conventional treatment.1-3
- 86% of patients experienced treatment success after receiving SCS therapy for one-year*4
- Proven long-term therapy for managing chronic pain with the majority of patients experiencing meaningful pain relief through five years of treatment with SCS.4
17x
more likely to
experience significant
pain relief1-3
86%
of patients experienced treatment success after receiving SCS therapy
for 1-year*4
5yrs
of meaningful
pain relief4
Understand the risks
Risks include infection, lead movement, pain at the implant site, and loss of therapy effectiveness. Not everyone responds to SCS in the same way, and your patients’ experiences may vary. Risk of infection and severity of complications may be greater in diabetic patients.
Consider a preoperative risk assessment to determine if patients are healthy enough for surgery.
Monitor patients' glucose levels.
For a better understanding of risk and safety details associated with SCS therapy, and to get information about trials, procedures, benefits and features of Medtronic devices, download our brochures for referring physicians and implanters.
DTM™ SCS therapy
Differential Target Multiplexed™ (DTM) SCS is a superior Spinal Cord Stimulation therapy delivered via the Inceptiv™ and Intellis™ SCS platforms to treat patients with chronic, intractable back and leg pain.
The DTM™ SCS 12-month RCT proved sustained superiority compared to conventional stimulation.5
* Descriptive comparison, including studies with similar design (RCT; randomization >100 subjects; comparing 2 SCS therapies; with at least 12-months follow up) and patient populations (inclusion/exclusion criteria; baseline demographics) with back pain responder rates reported. This is not based on a statistical analysis of outcomes between studies.
*
Success rates in a population of patients treated with SCS in two studies and followed for five years.
1
Medtronic. Medtronic Pain Therapy Clinical Summary M221494A016 Rev B. United States; 2022.
2
de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: A multicenter randomized clinical trial. Pain. 2014;155(11):2426–2431. doi:10.1016/j.pain.2014.08.031.
3
Slangen R, Schaper NC, Faber CG, et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: A prospective two-center randomized controlled trial. Diabetes Care. 2014;37(11):3016–3024. doi:10.2337/dc14-0684.
4
van Beek M, Geurts JW, Slangen R, et al. Severity of neuropathy is associated with long-term spinal cord stimulation outcomes in painful diabetic peripheral neuropathy: Five-year follow-up of a prospective two-center clinical trial. Diabetes Care. 2018;41(1):32–38. doi:10.2337/dc17-0983.
5
Fishman M, Cordner H, Justiz R, et al. 12-Month Results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 00: 1–12. doi: 10.1111/papr.13066.